Sam Brusco, Associate Editor01.17.23
Spine technology firm VySpine has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its LumiVy NanoVy Ti lumbar IBF system for intervertebral body fusion at one level or two contiguous levels in the lumbar spine, from L2 to S1, to treat degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis.
LumiVy NanoVy features the company’s proprietary Ti coating, in partnership with Implant Surfaces. The titanium coating is nanometers thick and adhered to a PEEK (polyether-ether-ketone) LumiVy implant. The coating is designed to facilitate direct osteoblast attachment to the entire LumiVy implant surface.
NanoVy Ti coating is high-adhesion and impact-resistant, and bonds intimately to the PEEK structure. It’s been shown, according to the company, to boost the implant’s expulsion resistance. It also does this without compromising radiolucency of the PEEK material.
LumiVy NanoVy lumbar IBF comes in an array of footprints for “nearly any” lumbar interbody approach. It’s also available in a range of sizes, heights, and lordotic angles.
LumiVy NanoVy features the company’s proprietary Ti coating, in partnership with Implant Surfaces. The titanium coating is nanometers thick and adhered to a PEEK (polyether-ether-ketone) LumiVy implant. The coating is designed to facilitate direct osteoblast attachment to the entire LumiVy implant surface.
NanoVy Ti coating is high-adhesion and impact-resistant, and bonds intimately to the PEEK structure. It’s been shown, according to the company, to boost the implant’s expulsion resistance. It also does this without compromising radiolucency of the PEEK material.
LumiVy NanoVy lumbar IBF comes in an array of footprints for “nearly any” lumbar interbody approach. It’s also available in a range of sizes, heights, and lordotic angles.